Table 1 Bleeding risk scores for prophylactic anticoagulation
Bleeding risk factor | Heparin calcium (s.c.) | Enoxaparin (s.c.) | Fondaparinux (s.c.) | Edoxaban (p.o.) |
|---|---|---|---|---|
Age (years) | Â | Â | Â | Â |
  ≥ 75 | 1 | 1 | 1 | 1 |
  < 75 | 0 | 0 | 0 | 0 |
Weight (kg) | Â | Â | Â | Â |
  ≥ 50 | 0 | 0 | 0 | 0 |
  ≥ 40, < 50 | 1 | 1 | 1 | 1 |
  < 40 | 3 | 3 | 3 | 3 |
CLcr (mL/min) | Â | Â | Â | Â |
  ≥ 50 | 0 | 0 | 0 | 0 |
  ≥ 30, < 50 | 0 | 1 | 1 | 1 |
  ≥ 20, < 30 | 0 | 5 | 1 | 5 |
  < 20 | 5 | 5 | 6 | 5 |
Antiplatelet therapy | Â | Â | Â | Â |
 None | 0 | 0 | 0 | 0 |
 SAPT | Physician consultation | Physician consultation | Physician consultation | Physician consultation |
 DAPT | Physician consultation | Physician consultation | Physician consultation | Physician consultation |
P-gp inhibitors | Â | Â | Â | Â |
 None | 0 | 0 | 0 | 0 |
 1 | 0 | 0 | 0 | 1 |
  ≥ 2 | 0 | 0 | 0 | 2 |